Ahead of an expected surge in U.S. demand for prescription drugs, the Canadian government has blocked the distribution of certain medications outside the country if that sale would cause or worsen a drug shortage. The move comes in response to a new U.S. rule that would let pharmacists or wholesalers import certain prescription drugs in bulk from Canada. The rule was set to go into effect on Monday, but the Canadian government says it won’t comply if sales would cause or worsen a drug shortage. It may require companies to first assess potential shortages before any sales take place. (Reuters
Six events between now and Jan. 20 will set the agenda for the Biden administration, writes health policy analyst Paul Keckley, PhD. Among them are the Georgia senate runoffs, vaccine distribution, the potential shutdown and appointments to health care positions. “Drug prices, healthcare affordability and price transparency, consolidation of hospitals that result in higher costs, physician independence, the role of private equity ownership and the national deficit will once again dominate the healthcare industry’s attention. But how they are approached will be defined by what happens between now and January 20.” (The Keckley Report
Note: sources that have an asterisk require login to view the article.
In Case You Missed It!
The GTMRx’s Precision Medicine Enablement via Advanced Diagnostics Workgroup and Pharmacogenomics Payment and Policy Taskforce recently completed an evidence document
that articulates the value of pharmacogenomics in the context of comprehensive medication management. In this blog post, Jill S. Bates, PharmD, MS, BCOP, FASHP. National PHASER pharmacy program manager for the Department of Veterans Affairs, offers insights into what the task force learned. Read it here
December 9, 2020 | 12:00 – 1:00pm EST
- Purpose of the 21st Century Cures Act and its impact on Health IT
- Key implications of the ONC’s 11/2 Final Rule
- Future affects the act will have on CMM.
December 15, 2020 | 2:00 – 3:00pm EST
Jared Augenstein, MA, MPH, director, Manatt, Phelps & Phillips, LLP, to present to the GTMRx Payment and Policy Solutions Workgroup
. The following are the key subjects that will be addressed:
- Value telehealth will bring to the provider, patient and payer
- How COVID-19 will change CMM care
- Actions the government can take to improve availability and adoptability of telehealth
If you are interested in attending either presentation, please reach out to GTMRx Operations Manager, Izzy Serji, MPH, at [email protected]
, indicating which with the subject: “GTMRx Speaker: 12/9” or “GTMRx Speaker: 12/15”
AmazonSmile is an easy way for 0.5% of your qualified purchases go to the GTMRx Foundation at no cost to you. And signing up is simple—go to smile.amazon.com
and select “Get the Medications Right Foundation” as your charity of choice. If you prefer to directly donate instead, you can do so here
Adding the foundation on AmazonSmile will help us continue to provide no cost educational webinars, issue briefs, weekly news briefs and promote the need for transformation of our current system of medication use through social media campaigns.
See past issues of our weekly news brief here.